- Corporate Officers - C
- Cormorant Global Healthcare Master Fund, Lp
Insider Trading History of Cormorant Global Healthcare Master Fund, Lp
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cormorant Global Healthcare Master Fund, Lp since 2016.
This trader's CIK number is 1618442.
At the time of last reporting, Cormorant Global Healthcare Master Fund, Lp was the Officer of Corbus Pharmaceuticals Holdings, Inc.. (stock ticker symbol CRBP).
Also see all insider trading activities at Corbus Pharmaceuticals Holdings, Inc..
Note that in the past
Cormorant Global Healthcare Master Fund, LP also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Axonics, Inc. (AXNX) by Cormorant Global Healthcare Master Fund, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | AXNX | 133,333 | $1,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Eyepoint Pharmaceuticals, Inc. (EYPT) by Cormorant Global Healthcare Master Fund, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | EYPT | 2,286,765 | $37,899,628 | 0 | $0 | 0 | $0 |
| 2023 | EYPT | 2,507,292 | $61,465,265 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kineta, Inc./de (PTI) by Cormorant Global Healthcare Master Fund, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | PTI | 0 | $0 | 504,027 | $2,461,163 | 0 | $0 |
| 2016 | PTI | 1,289,868 | $13,145,400 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kiniksa Pharmaceuticals International, Plc (KNSA) by Cormorant Global Healthcare Master Fund, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | KNSA | 69,444 | $1,249,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Cormorant Global Healthcare Master Fund, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CRBP | 900,000 | $29,989,450 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kezar Life Sciences, Inc. (KZR) by Cormorant Global Healthcare Master Fund, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | KZR | 250,000 | $3,750,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Cormorant Global Healthcare Master Fund, Lp:
1. Axonics, Inc. (AXNX)
2. Eyepoint Pharmaceuticals, Inc. (EYPT)
3. Kineta, Inc./de (PTI)
4. Kiniksa Pharmaceuticals International, Plc (KNSA)
5. Corbus Pharmaceuticals Holdings, Inc. (CRBP)
6. Kezar Life Sciences, Inc. (KZR)
Table 1. Insider trading of Axonics, Inc. (AXNX) by Cormorant Global Healthcare Master Fund, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-10-31 | AXNX | Buy | 133,333 | 15.00 | 1,999,995 |
Table 2. Insider trading of Eyepoint Pharmaceuticals, Inc. (EYPT) by Cormorant Global Healthcare Master Fund, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-05-06 | EYPT | Buy | 850,000 | 12.03 | 10,225,500 |
| 2024-04-18 | EYPT | Buy | 581,765 | 18.26 | 10,623,028 |
| 2024-01-09 | EYPT | Buy | 105,000 | 21.32 | 2,238,600 |
| 2024-01-11 | EYPT | Buy | 750,000 | 19.75 | 14,812,500 |
| 2023-12-08 | EYPT | Buy | 588,235 | 17.00 | 9,999,995 |
| 2023-12-04 | EYPT | Buy | 1,919,057 | 26.82 | 51,465,270 |
Table 3. Insider trading of Kineta, Inc./de (PTI) by Cormorant Global Healthcare Master Fund, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-12-14 | PTI | Sale | 504,027 | 4.88 | 2,461,163 |
| 2016-12-13 | PTI | Buy | 21,301 | 10.98 | 233,948 |
| 2016-12-12 | PTI | Buy | 100,000 | 10.79 | 1,079,000 |
| 2016-12-07 | PTI | Buy | 22,598 | 10.74 | 242,702 |
| 2016-12-08 | PTI | Buy | 21,819 | 10.93 | 238,481 |
| 2016-12-02 | PTI | Buy | 50,000 | 10.48 | 523,800 |
| 2016-12-06 | PTI | Buy | 8,216 | 10.89 | 89,439 |
| 2016-12-05 | PTI | Buy | 29,757 | 10.78 | 320,869 |
| 2016-12-02 | PTI | Buy | 50,000 | 10.48 | 523,800 |
| 2016-12-06 | PTI | Buy | 8,216 | 10.89 | 89,439 |
| 2016-12-05 | PTI | Buy | 29,757 | 10.78 | 320,869 |
| 2016-12-02 | PTI | Buy | 50,000 | 10.48 | 523,800 |
| 2016-12-06 | PTI | Buy | 8,216 | 10.89 | 89,439 |
| 2016-12-05 | PTI | Buy | 29,757 | 10.78 | 320,869 |
| 2016-12-01 | PTI | Buy | 41,984 | 10.11 | 424,584 |
| 2016-11-29 | PTI | Buy | 128,407 | 10.28 | 1,319,510 |
| 2016-11-23 | PTI | Buy | 180,500 | 11.02 | 1,989,290 |
| 2016-11-22 | PTI | Buy | 69,500 | 11.08 | 769,851 |
| 2016-11-21 | PTI | Buy | 111,863 | 11.64 | 1,302,644 |
| 2016-11-04 | PTI | Buy | 76,000 | 7.68 | 583,756 |
| 2016-11-07 | PTI | Buy | 231,700 | 8.69 | 2,012,546 |
| 2016-11-03 | PTI | Buy | 20,277 | 7.24 | 146,764 |
Table 4. Insider trading of Kiniksa Pharmaceuticals International, Plc (KNSA) by Cormorant Global Healthcare Master Fund, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-29 | KNSA | Buy | 69,444 | 18.00 | 1,249,992 |
Table 5. Insider trading of Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Cormorant Global Healthcare Master Fund, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-09-20 | CRBP | Buy | 350,000 | 19.93 | 6,974,800 |
| 2024-03-08 | CRBP | Buy | 300,000 | 43.76 | 13,128,900 |
| 2024-03-07 | CRBP | Buy | 250,000 | 39.54 | 9,885,750 |
Table 6. Insider trading of Kezar Life Sciences, Inc. (KZR) by Cormorant Global Healthcare Master Fund, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-06-25 | KZR | Buy | 250,000 | 15.00 | 3,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cormorant Global Healthcare Master Fund, Lp
(Officer of Corbus Pharmaceuticals Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.